This inventor holds 1 USPTO granted patent. Top assignees: Cellec Biotek Ag, University Hospital of Basel. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Stefania Adele Riboldi: Innovator in Bioreactor Technology
Introduction
Stefania Adele Riboldi is a notable inventor based in Biassono, Italy. She has made significant contributions to the field of bioreactor technology, particularly in the area of three-dimensional cell culturing. Her innovative designs aim to enhance the efficiency and safety of bioreactor operations.
Latest Patents
Stefania holds a patent for a bioreactor and rack for mounting bioreactors. This bioreactor is designed for preferably three-dimensional cell culturing and comprises a scaffold chamber, a first tube, a second tube, and a first valve with a scaffold adapter, a tube adapter, and a medium adapter. The first valve features a housing with a longitudinal female portion that ends in an opening, along with a longitudinal actuator arranged through the opening. The actuator is partially inside and partially outside the housing, allowing for axial movement. This design enables the actuator to shift between an operational position and a medium change position, simplifying the operation of the bioreactor.
Career Highlights
Throughout her career, Stefania has worked with esteemed organizations such as the University Hospital of Basel and Cellec Biotek AG. Her experience in these institutions has contributed to her expertise in biotechnological innovations.
Collaborations
Stefania has collaborated with notable professionals in her field, including Elia Piccinini and David Wendt. These partnerships have further enriched her work and expanded her impact in bioreactor technology.
Conclusion
Stefania Adele Riboldi is a pioneering inventor whose work in bioreactor technology is shaping the future of cell culturing. Her innovative designs and collaborations highlight her commitment to advancing biotechnological solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile